Search by Drug Name or NDC
NDC 00409-6727-50 Magnesium Sulfate in Dextrose 10 mg/mL Details
Magnesium Sulfate in Dextrose 10 mg/mL
Magnesium Sulfate in Dextrose is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
| NDC | 00409-6727 |
|---|---|
| Product ID | 0409-6727_7c690dc0-a5dd-415b-9c97-12f367c13bc9 |
| Associated GPIs | 79400010412032 |
| GCN Sequence Number | 063498 |
| GCN Sequence Number Description | magnesium sulfate/D5W PIGGYBACK 1 G/100 ML INTRAVEN |
| HIC3 | C1H |
| HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
| GCN | 99224 |
| HICL Sequence Number | 006306 |
| HICL Sequence Number Description | MAGNESIUM SULFATE/DEXTROSE 5 % IN WATER |
| Brand/Generic | Generic |
| Proprietary Name | Magnesium Sulfate in Dextrose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Magnesium Sulfate in Dextrose |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020488 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-6727-50 (00409672750)
| NDC Package Code | 0409-6727-50 |
|---|---|
| Billing NDC | 00409672750 |
| Package | 50 POUCH in 1 CASE (0409-6727-50) / 1 BAG in 1 POUCH / 100 mL in 1 BAG (0409-6727-55) |
| Marketing Start Date | 2022-12-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |